198
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Incidence and Risk Factors of Lower-Extremity Deep Vein Thrombosis After Thrombolysis Among Patients with Acute Ischemic Stroke

ORCID Icon, , , , , & ORCID Icon show all
Pages 1107-1114 | Published online: 04 Sep 2021

References

  • Dennis M, Sandercock P, Graham C, Forbes J, Forbes J on behalf of the CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration. The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness. Health Technol Assess. 2015;19(76):1–90. doi:10.3310/hta19760
  • Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388(10063):3060–3073. doi:10.1016/S0140-6736(16)30514-1
  • Khan MT, Ikram A, Saeed O, et al. Deep vein thrombosis in acute stroke – a systemic review of the literature. Cureus. 2017;9:e1982. doi:10.7759/cureus.1982
  • Baloqun IO, Roberts LN, Patel R, Pathansali R, Kalra L, Arya R. Clinical and laboratory predictors of deep vein thrombosis after acute stroke. Thromb Res. 2016;142:33–39. doi:10.1016/j.thromres.2016.04.002
  • Ji R, Li G, Zhang R, Hou H, Zhao X, Wang Y. Higher risk of deep vein thrombosis after hemorrhagic stroke than after acute ischemic stroke. J Vasc Nurs. 2019;37:18–27. doi:10.1016/j.jvn.2018.10.006
  • Ha SH, Kim YJ, Heo SH, Chang DI, Kim BJ. Prediction of deep vein thrombosis by ultrasonography and D-dimer in Asian patients with ischemic stroke. BMC Neurol. 2020;20:257. doi:10.1186/s12883-020-01842-w
  • Wang Y, Shi Y, Dong Y, Dong Q, Ye T, Fang K. Clinical risk factors of asymptomatic deep venous thrombosis in patients with acute stroke. Clin Appl Thromb Hemost. 2019;25:1076029619868534. doi:10.1177/1076029619868534
  • Tang WJ, Shi ZX, Zhang CY, Hu Z. Risk factors of deep venous thrombosis in stroke patients: a Meta-analysis. Chin J Nurs. 2019;54:989–994. doi:10.3761/j.issn.0254-1769.2019.07.006
  • Furie KL, Jayaraman MV. 2018 Guidelines for the early management of patients with acute ischemic stroke. Stroke. 2018;49:509–510. doi:10.1161/STROKEAHA.118.020176
  • Chen P, Wan G, Zhu B. Incidence and risk factors of symptomatic thrombosis related to peripherally inserted central catheter in patients with lung cancer. J Adv Nurs. 2021;77:1284–1292. doi:10.1111/jan.14666
  • Pilato F, Calandrelli R, Profice P, et al. Pulmonary embolism in a stroke patient after systemic thrombolysis: clinical decisions and literature review. J Stroke Cerebrovasc Dis. 2013;22:e667–70. doi:10.1016/j.jstrokecerebrovasdis.2013.06.016
  • Shaikhouni A, Baum J, Lonser RR. Deep vein thrombosis prophylaxis in the neurosurgical patient. Neurosurg Clin N Am. 2018;29:567–574. doi:10.1016/j.nec.2018.06.010
  • Fassbender K, Dempfle CE, Mielke O, et al. Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator. Stroke. 1999;30:2101–2104. doi:10.1161/01.str.30.10.2101
  • Dizon MAM, De Leon JM. Effectiveness of initiating deep vein thrombosis prophylaxis in patients with stroke: an integrative review. J Neurosci Nurs. 2018;50:308–312. doi:10.1097/JNN.0000000000000385
  • Douds GL, Hellkamp AS, Olson DM, et al. Venous thromboembolism in the Get With The Guidelines-Stroke acute ischemic stroke population: incidence and patterns of prophylaxis. J Stroke Cerebrovasc Dis. 2014;23:123–129. doi:10.1016/j.jstrokecerebrovasdis.2012.10.018
  • Delgado MG, Mauri G, Vega J. Massive pulmonary thromboembolism after intravenous stroke thrombolysis. BMJ Case Rep. 2012;bcr1020115008. doi:10.1136/bcr.10.2011.5008
  • Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50:e344–e418. doi:10.1161/STR.0000000000000211
  • Wang X, Zhou YC, Zhu WD, et al. The risk of postoperative hemorrhage and efficacy of heparin for preventing deep vein thrombosis and pulmonary embolism in adult patients undergoing neurosurgery: a systematic review and meta-analysis. J Investig Med. 2017;65:1136–1146. doi:10.1136/jim-2016-000235
  • Li X, Tong X, Li -J-J, et al. Meta-analysis of safety and efficacy of early antithrombotic therapy in patients with acute ischemic stroke after intravenous alteplase thrombolysis. Chin J Stroke. 2008;13:430–436. doi:10.3969/j.issn.1673-5765.2018.05.005
  • Turpie AGG, Esmon C. Venous and arterial thrombosis – pathogenesis and the rationale for anticoagulation. Thromb Haemost. 2011;105:586–596. doi:10.1160/TH10-10-0683
  • Evans NS, Ratchford EV. Catheter-related venous thrombosis. Vasc Med. 2018;23:411–413. doi:10.1177/1358863X18779695
  • Liu LP, Zheng HG, Wang DZ, et al. Risk assessment of deep-vein thrombosis after stroke: a prospective study using clinical factors. CNS Neurosci Ther. 2014;20:403–410. doi:10.1111/cns.12227
  • Danish SF, Burnett MG, Stein SC. Prophylaxis for deep venous thrombosis in patients with craniotomies: a review. Neurosurg Focus. 2004;17:E2. doi:10.3171/foc.2004.17.4.2
  • Li Q, Dai B, Yao Y, Song K, Chen D, Jiang Q. Chronic kidney dysfunction can increase the risk of deep vein thrombosis after total hip and knee arthroplasty. Biomed Res Int. 2017;2017:8260487. doi:10.1155/2017/8260487
  • Fujita Y, Nakatsuka H, Namba Y, et al. The incidence of pulmonary embolism and deep vein thrombosis and their predictive risk factors after lower extremity arthroplasty: a retrospective analysis based on diagnosis using multidetector CT. J Anesth. 2015;29:235–241. doi:10.1007/s00540-014-1891-x
  • Dai X, Ding W, Li H, et al. Associations of serum lipids and deep venous thrombosis risk after total knee arthroplasty in patients with primary knee osteoarthritis. Int J Low Extrem Wounds. 2020;19:51–56. doi:10.1177/1534734619868123
  • Sung Y, Spagou K, Kafeza M, et al. Deep vein thrombosis exhibits characteristic serum and vein wall metabolic phenotypes in the inferior vena cava ligation mouse model. Eur J Vasc Endovasc Surg. 2018;55:703–713. doi:10.1016/j.ejvs.2018.01.027
  • Zakai NA, Ohira T, White R, Folsom AR, Cushman M. Activated partial thromboplastin time and risk of future venous thromboembolism. Am J Med. 2008;121:231–238. doi:10.1016/j.amjmed.2007.10.025
  • Hron G, Eichinger S, Weltermann A, Quehenberger P, Halbmayer WM, Kyrle PA. Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time. J Thrombosis Haemostasis. 2006;4:752–756. doi:10.1111/j.1538-7836.2006.01868.x
  • Ciccone MM, Aquilino A, Cortese F, et al. Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo). Vasc Health Risk Manag. 2010;6:297–305. doi:10.2147/VHRM.S9252
  • Serpici A, Gürsoy A. Nurse-led patient training improves deep vein thrombosis knowledge and self-care practices. J Vasc Nurs. 2018;36:53–63. doi:10.1016/j.jvn.2018.03.002